Résumé
Avec 750 000 nouveaux cas par an aux États-Unis, les accidents vasculaires cérébraux (AVC) demeurent la troisième cause de mortalité dans le monde, et certainement la première cause d’invalidité [1, 2]. Les AVC hémorragiques représentent 10 à 15 % de l’ensemble des AVC soit 10 à 20 cas par 100 000 habitants [3]. L’incidence augmente avec l’âge surtout au-delà de 55 ans, mais il existe également des facteurs génétiques. Chez les sujets de race noire ou les Japonais, l’incidence des AVC hémorragiques est deux fois plus élevée que dans le reste de la population [4]. Parmi les facteurs génétiques, O’Donnell et al. ont montré que la présence des allèles e2 et e4 sur les gènes codant pour l’apolipoprotéine E était associée à un risque trois fois plus important de récidive hémorragique [5]. L’AVC hémorragique est une pathologie grave, avec une mortalité à 30 jours comprise entre 35 et 52 % [6]. La moitié des décès surviennent dans les 48 premières heures suivant l’AVC. La survie à un an et à cinq ans est respectivement d’environ 42 et 27 % [7]. Seize ans après l’accident initial, seulement 19,3 % des patients de moins de 65 ans sont toujours en vie. L’admission dans des centres ayant l’habitude de prendre en charge ces patients améliore le pronostic. Comme pour l’AVC ischémique, la prise en charge des AVC hémorragiques dans une unité neurovasculaire diminue la mortalité, qui passe de 69 % à 52 % à un an.
Preview
Unable to display preview. Download preview PDF.
Références
Feigin VL, Lawes CM, Bennett DA, Anderson CS (2003) Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2: 43–53
Sudlow CL, Warlow CP (1997) Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 28: 491–9
Qureshi AI, Tuhrim S, Broderick JP, et al. (2001) Spontaneous intracerebral hemorrhage. N Engl J Med 344: 1450–60
Qureshi AI, Giles WH, Croft JB (1999) Racial differences in the incidence of intracerebral hemorrhage: effects of blood pressure and education. Neurology 52: 1617–21
O’Donnell HC, Rosand J, Knudsen KA, et al. (2000) Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 342: 240–5
Ronning OM, Guldvog B, Stavem K (2001) The benefit of an acute stroke unit in patients with intracranial haemorrhage: a controlled trial. J Neurol Neurosurg Psychiatry 70: 631–4
Fogelholm R, Murros K, Rissanen A, Avikainen S (2005) Long term survival after primary intracerebral haemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry 76: 1534–8
Diringer MN, Edwards DF (2001) Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 29: 635–40
Feldmann E, Broderick JP, Kernan WN, et al. (2005) Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 36: 1881–5
Brott T, Thalinger K, Hertzberg V (1986) Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 17: 1078–83
Mayer SA, Rincon F (2005) Treatment of intracerebral haemorrhage. Lancet Neurol 4: 662–72
Fogelholm R, Eskola K, Kiminkinen T, Kunnamo I (1992) Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 55: 1121–4
Franke CL, de Jonge J, van Swieten JC, et al. (1990) Intracerebral hematomas during anticoagulant treatment. Stroke 21: 726–30
He J, Whelton PK, Vu B, Klag MJ (1998) Aspirin and risk of hemorrhagic stroke: a metaanalysis of randomized controlled trials. Jama 280: 1930–5
Hart RG, Benavente O, Pearce LA (1999) Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovasc Dis 9: 215–7
Thrift AG, McNeil JJ, Forbes A, Donnan GA (1999) Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study. BMJ 318: 759–64
Rosand J, Eckman MH, Knudsen KA, et al. (2004) The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164: 880–4
Oden A, Fahlen M (2002) Oral anticoagulation and risk of death: a medical record linkage study. BMJ 325: 1073–5
Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352: 1305–16
Sloan MA, Price TR, Petito CK, et al. (1995) Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 45: 649–58
Schellinger P, Fiebach J, Mohr A, et al. (2001) Thrombolytic therapy for ischemic stroke-A review. Part I-Intravenous thrombolysis. Crit Care Med 29: 1812–8
Larrue V, von Kummer RR, Muller A, Bluhmki E (2001) Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32: 438–41
Sansing LH, Messe SR, Cucchiara BL, et al. (2009) Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology 72: 1397–1402
Naidech AM, Jovanovic B, Liebling S, et al. (2009) Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke 40: 2398–2401
Lauer A, Schlunk F, Van Cott EM, et al. (2011) Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 31: 1736–42
Ahrens I, Lip GY, Peter K (2011) What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation? Thromb Haemost 105: 574–8
Rosencher N, Bellamy L (2009) [Dabigatran (Pradaxa): efficacy and safety]. Ann Fr Anesth Reanim 28: S15–22
Stead LG, Jain A, Bellolio MF, et al. (2010) Emergency Department hyperglycemia as a predictor of early mortality and worse functional outcome after intracerebral hemorrhage. Neurocrit Care 13: 67–74
Liu J, Gao BB, Clermont AC, et al. (2011) Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nat Med 17: 206–10
Nieswandt B, Stoll G (2011) Sugar rush bleeds the brain. Nat Med 17: 161–2
Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. (2001) The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32: 891–7
Gebel JM, Sila CA, Sloan MA, et al. (1998) Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial. Stroke 29: 1799–1801
Brott T, Broderick J, Kothari R, et al. (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28: 1–5
Kazui S, Naritomi H, Yamamoto H, et al. (1996) Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 27: 1783–7
Fogelholm R, Avikainen S, Murros K (1997) Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 28: 1396–1400
Ohwaki K, Yano E, Nagashima H, et al. (2004) Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 35: 1364–7
Moon JS, Janjua N, Ahmed S, et al. (2008) Prehospital neurologic deterioration in patients with intracerebral hemorrhage. Crit Care Med 36: 172–5
Marti-Fabregas J, Belvis R, Guardia E, et al. (2003) Prognostic value of Pulsatility Index in acute intracerebral hemorrhage. Neurology 61: 1051–6
Ko SB, Choi HA, Parikh G, et al. (2011) Multimodality monitoring for cerebral perfusion pressure optimization in comatose patients with intracerebral hemorrhage. Stroke 42: 3087–92
De Herdt V, Dumont F, Henon H, et al. (2011) Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology 77: 1794–1800
Yang TM, Lin WC, Chang WN, et al. (2009) Predictors and outcome of seizures after spontaneous intracerebral hemorrhage. Clinical article. J Neurosurg 111: 87–93
Claassen J, Jette N, Chum F, et al. (2007) Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology 69: 1356–65
Vespa PM, O’Phelan K, Shah M, et al. (2003) Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 60: 1441–6
Naidech AM, Garg RK, Liebling S, et al. (2009) Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke 40: 3810–5
Rost NS, Smith EE, Chang Y, et al. (2008) Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke 39: 2304–9
Kelly PJ, Furie KL, Shafqat S, et al. (2003) Functional recovery following rehabilitation after hemorrhagic and ischemic stroke. Arch Phys Med Rehabil 84: 968–72
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Paris
About this chapter
Cite this chapter
Bruder, N., Velly, L. (2013). Accident vasculaire cérébral hémorragique. In: Accident vasculaire cérébral et réanimation. Le point sur…. Springer, Paris. https://doi.org/10.1007/978-2-287-99031-1_5
Download citation
DOI: https://doi.org/10.1007/978-2-287-99031-1_5
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-99030-4
Online ISBN: 978-2-287-99031-1
eBook Packages: MedicineMedicine (R0)